LMR 15

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

High affinity to ?: ARSENIC

keratin

Visible region ? nm

400 to 700 nm

? region: 400 to 700 nm

Visible

UV region ? nm

<400 nm

? region <400 nm

Infrared region ? nm

> 700

? region > 700 nm

Infrared

?, acceptable CV ≤ 3%

Cholesterol

Cholesterol, acceptable CV ?

≤ 3%

?, acceptable CV ≤ 5%

Triglyceride

Triglyceride, acceptable CV?

≤ 5%

HDLc, LDLc acceptable CV?

≤ 4%

? acceptable CV ≤ 4%

HDLc, LDLc

OBESE BMI =

30 kg/sq.m

= 30 kg/sq.m

OBESE BMI

Overweight BMI

25 to 29.9 kg/sq.m.

? BMI 25 to 29.9 kg/sq.m.

Overweight

Underweight BMI ?

< 18.5 kg/sq.m.

? BMI < 18.5 kg/sq.m.

Underweight

: early morning before the patient has eaten or become physically active

BASAL STATE

for the Latin word statim meaning immediately

STAT

Tests that fall into this category include: ? in diabetic ketoacidosis

Glucose

Tests that fall into this category include: Glucose in ?

diabetic ketoacidosis

Tests that fall into this category include: ? in suspected pancreatitis

Amylase

Tests that fall into this category Some drug levels such as ?

theophylline

Tests that fall into this category Amylase in suspected

pancreatitis

Tests that fall into this category in suspected MI

Tests that fall into this category CK in suspected ?

: list of analytes that truly do have the potential to be lethal if unchecked for a short period.

CRITICAL VALUES or PANIC VALUES

: Laboratory determination of vitamin B12 absorption

SCHILLING TEST

SCHILLING TEST: Laboratory determination of ? absorption

vitamin B12

Hemostatic mechanisms comprise four (4) main systems: the ?

vascular system, platelets, coagulation system and fibrinolytic system.

Osmolality =

2Na + (Glucose/20) + (BUN/3)

Osmolality =

1.86Na + (Glucose/18) + (BUN/2.8) + 9

Anion gap

a. AG = Na - (Cl + HCO3) b. AG = (Na + K) – (Cl + HCO3)

NORMAL URINARY CRYSTALS Uric acid is ? soluble

alkali

NORMAL URINARY CRYSTALS is alkali soluble

Uric acid

NORMAL URINARY CRYSTALS - soluble in alkali and heat

Amorphous urates

NORMAL URINARY CRYSTALS Amorphous urates - soluble in

alkali and heat

NORMAL URINARY CRYSTALS - soluble in dilute HCl

CaOx

NORMAL URINARY CRYSTALS CaOx - soluble in

dilute HCl

NORMAL URINARY CRYSTALS - soluble in dilute acetic acid

CAT Calcium phosphate Amorphous phosphates Triple phosphate

NORMAL URINARY CRYSTALS Amorphous phosphates - soluble in

dilute acetic acid

Calcium phosphate - soluble in

dilute acetic acid

Triple phosphate - soluble in

dilute acetic acid

Ammonium biurate - soluble in

acetic acid with heat

- soluble in acetic acid with heat

Ammonium biurate

Calcium carbonate - forms

gas from acetic acid

- forms gas from acetic acid

Calcium carbonate

ABNORMAL URINARY CRYSTALS is soluble in ammonia, dilute HC

Cystine

ABNORMAL URINARY CRYSTALS Cystine is soluble in

ammonia, dilute HC

ABNORMAL URINARY CRYSTALS is soluble in chloroform

Cholesterol

ABNORMAL URINARY CRYSTALS Cholesterol is soluble in

chloroform

ABNORMAL URINARY CRYSTALS is soluble in hot alkali or alcohol

Leucine

ABNORMAL URINARY CRYSTALS Leucine is soluble in

hot alkali or alcohol

ABNORMAL URINARY CRYSTALS is soluble in alkali or heat

Tyrosine

ABNORMAL URINARY CRYSTALS Tyrosine is soluble in ?

alkali or heat

is soluble in acetic acid, HCl, NaOH, ether and chloroform

Bilirubin

soluble in acetone

Sulfonamides

Sulfonamides soluble in

acetone

Bilirubin is soluble in

acetic acid, HCl, NaOH, ether and chloroform

soluble in 10% NaOH

Radiographic dye

Radiographic dye soluble in

10% NaOH

form bundles when refrigerated

Ampicillin crystals

is a very small, strictly aerobic, coccoid to pleomorphic rod-shaped, gram-negative bacillus that requires CYSTINE or CYSTEINE for growth

F. tularensis

F. tularensis is a very small, strictly aerobic, coccoid to pleomorphic rod-shaped, gram-negative bacillus that requires ? for growth

CYSTINE or CYSTEINE

. may be isolated on BCYE agar supplemented with growth factors, including LCYSTINE, FERRIC SALT, AND Α-KETOGLUTARATE.

Legionella spp

Legionella spp. may be isolated on BCYE agar supplemented with growth factors, including ?

LCYSTINE, FERRIC SALT, AND Α-KETOGLUTARATE.

are strictly aerobic, nonfermentative, catalase-positive, minute coccobacilli requiring NICOTINIC ACID, CYSTEINE, and usually METHIONINE, for growth.

Bordetella spp.

Bordetella spp. are strictly aerobic, nonfermentative, catalase-positive, minute coccobacilli requiring ?(2) , and usually ?, for growth.

NICOTINIC ACID, CYSTEINE, METHIONINE

is misconduct or lack of skill by a health-care professional that results in injury to the patient

MEDICAL MALPRACTICE

, which is defined as failure to give reasonable care by the health-care provider, must be proven in a malpractice suit

NEGLIGENCE

is the specimen of choice for the determination of circulating concentrations of most drugs.

SERUM or PLASMA

SERUM or PLASMA is the specimen of choice for the determination of circulating concentrations of most drugs.

THERAPEUTIC DRUGS

Analysis for the presence of ? has focused primarily on the use of URINE as the test sample of choice. The urine specimen represents the net load of the drug over a long period, whereas the blood sample provides only a quick picture of the drug level at a specific time. DRUGS OF ABUSE, CALBREATH

ABUSED SUBSTANCES

Analysis for the presence of ABUSED SUBSTANCES has focused primarily on the use of ? as the test sample of choice. It specimen represents the net load of the drug over a long period, whereas the blood sample provides only a quick picture of the drug level at a specific time. DRUGS OF ABUSE, CALBREATH

URINE

DRUGS OF ABUSE, CALBREATH

Processing steps for such specimens—initial collection, transportation, storage, and analytical testing— must be documented by careful record keeping. Documentation ensures that there has been no tampering with the specimen by any interested parties, that the specimen has been collected from the appropriate person, and that the results reported are accurate.

CHAIN OF CUSTODY

Each step of the COLLECTION, HANDLING, PROCESSING, TESTING, AND REPORTING PROCESSES must be documented; this is called the

CHAIN OF CUSTODY

are fragments of degenerating proliferative synovial cells or microinfarcted synovium.

RICE BODIES

, ground pepper appearance from pigmented cartilage fragments may be the result of a metabolic disorder (i.e., ?).

OCHRONOTIC SHARDS, ochronosis

PROBLEMS: RBCs appear gray, WBCs are too dark, eosinophil granules are gray, not orange. CAUSES: Stain or buffer ? (most common),

too alkaline, inadequate rinsing, prolonged staining, heparinized blood sample.

PROBLEMS: RBCs are too pale or are RED, WBCs are barely visible. CAUSES: Stain or buffer ? (most common), underbuffering (too short), over-rinsing.

too acidic, underbuffering (too short), over-rinsing.

indicates HIGH INFECTIVITY.

HBeAg

HBeAg indicates .

HIGH INFECTIVITY

SPECIAL URINE PRESERVATIVES – for Addis count

Formaldehyde

, or percutaneous umbilical blood sampling (PUBS)

CORDOCENTESIS

SPECIAL URINE PRESERVATIVES – for epinephrine, norepinephrine, catecholamines, vanillylmandelic acid

Conc, HCl

SPECIAL URINE PRESERVATIVES pH 4.5 – for aldosterone

Glacial acetic acid ; Chloroform –

SPECIAL URINE PRESERVATIVES Glacial acetic acid pH ? – for aldosterone

4.5

SPECIAL URINE PRESERVATIVES Glacial acetic acid pH 4.5 – for ?

aldosterone

SPECIAL URINE PRESERVATIVES . – for porphyrins and urobilinogen (to ensure alkalinity)

Sodium carbonate

SPECIAL URINE PRESERVATIVES . Sodium carbonate – for ? (to ensure alkalinity)

porphyrins and urobilinogen

SPECIAL URINE PRESERVATIVES . Glacial acetic acid pH 2.0 – for

serotonin

SPECIAL URINE PRESERVATIVES . Glacial acetic acid pH ? – for serotonin

2.0

SPECIAL URINE PRESERVATIVES pH 2.0 – for serotonin

. Glacial acetic acid

SPECIAL URINE PRESERVATIVES – for steroids, ammonia, urea, total nitrogen

Conc. HCl

SPECIAL URINE PRESERVATIVES – preserves calcium and other inorganic constituents

Sulfuric acid

SPECIAL URINE PRESERVATIVES – ideal for glucose analysis, prevents glycolysiS

Sodium fluoride or benzoic acid

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前